Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2 -infected patients: the ACHIEV2E Collaboration Study Group

A Benard; A van Sighem; A Taieb; E Valadas; V Soriano; A Calmy; C Balotta; F Damond; F Brun-Vezinet; G Chene; S Matheron; null The ACHIEV2E Collaboration Study Group

Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2 -infected patients: the ACHIEV2E Collaboration Study Group

A Benard, A van Sighem, A Taieb, E Valadas, V Soriano, A Calmy, C Balotta, F Damond, F Brun-Vezinet, G Chene, S Matheron, The ACHIEV2E Collaboration Study Group

Research output: Contribution to journal › Article › Academic › peer-review

34 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1257-1266
Number of pages	10
Journal	Clinical Infectious Diseases
Volume	52
Publication status	Published - 2011
Externally published	Yes

Research programs

EMC MM-04-28-04
EMC MM-04-54-08-A

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Benard, A., van Sighem, A., Taieb, A., Valadas, E., Soriano, V., Calmy, A., Balotta, C., Damond, F., Brun-Vezinet, F., Chene, G., Matheron, S., & The ACHIEV2E Collaboration Study Group (2011). Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2 -infected patients: the ACHIEV2E Collaboration Study Group. Clinical Infectious Diseases, 52, 1257-1266.

@article{ca899869ea564d6d8961e72730894d23,

title = "Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2 -infected patients: the ACHIEV2E Collaboration Study Group",

author = "A Benard and {van Sighem}, A and A Taieb and E Valadas and V Soriano and A Calmy and C Balotta and F Damond and F Brun-Vezinet and G Chene and S Matheron and {The ACHIEV2E Collaboration Study Group}",

year = "2011",

language = "Undefined/Unknown",

volume = "52",

pages = "1257--1266",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

}

Benard, A, van Sighem, A, Taieb, A, Valadas, E, Soriano, V, Calmy, A, Balotta, C, Damond, F, Brun-Vezinet, F, Chene, G, Matheron, S & The ACHIEV2E Collaboration Study Group 2011, 'Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2 -infected patients: the ACHIEV2E Collaboration Study Group', Clinical Infectious Diseases, vol. 52, pp. 1257-1266.

Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2 -infected patients: the ACHIEV2E Collaboration Study Group. / Benard, A; van Sighem, A; Taieb, A et al.
In: Clinical Infectious Diseases, Vol. 52, 2011, p. 1257-1266.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2 -infected patients: the ACHIEV2E Collaboration Study Group

AU - Benard, A

AU - van Sighem, A

AU - Taieb, A

AU - Valadas, E

AU - Soriano, V

AU - Calmy, A

AU - Balotta, C

AU - Damond, F

AU - Brun-Vezinet, F

AU - Chene, G

AU - Matheron, S

AU - The ACHIEV2E Collaboration Study Group, null

PY - 2011

Y1 - 2011

M3 - Article

SN - 1058-4838

VL - 52

SP - 1257

EP - 1266

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

ER -